For OIP5‐AS1, it was found to impede characteristics associated with Parkinson's disease, as it reduced alpha‐synuclein aggregation and toxicity via miR‐126 binding, yielding reduced rates of apoptosis and neuron loss.92 Here, OIP5 is linked to Parkinson disease.